APA (7th ed.) Citation

Caillet, A., Simonet‐Boissard, M., Forcade, E., Robin, M., Rubio, M., Couturier, M., . . . Berceanu, A. (2024). IDALLO study: A retrospective multicenter study of the SFGM‐TC evaluating the efficacy and safety of ivosidenib in relapsed IDH1‐mutated AML after allogeneic hematopoietic cell transplantation. Wiley. https://doi.org/10.1002/hem3.44

Chicago Style (17th ed.) Citation

Caillet, Adrien, et al. IDALLO Study: A Retrospective Multicenter Study of the SFGM‐TC Evaluating the Efficacy and Safety of Ivosidenib in Relapsed IDH1‐mutated AML After Allogeneic Hematopoietic Cell Transplantation. Wiley, 2024. https://doi.org/10.1002/hem3.44.

MLA (9th ed.) Citation

Caillet, Adrien, et al. IDALLO Study: A Retrospective Multicenter Study of the SFGM‐TC Evaluating the Efficacy and Safety of Ivosidenib in Relapsed IDH1‐mutated AML After Allogeneic Hematopoietic Cell Transplantation. Wiley, 2024. https://doi.org/10.1002/hem3.44.